title: Clinical and image improvement of Raynaud's phenomenon after botulinum toxin type A treatment.
abstract: Raynaud's phenomenon is often accompanied by pain, digital ulceration and compromised daily activities. Pharmacological therapy or sympathectomies have been administered to diminish these symptoms but existing treatments are not invariably efficacious. A recent case series has described the use of botulinum toxin type A in the treatment of Raynaud's phenomenon. We report two patients with severe or mild Raynaud's phenomenon who were injected with BTX-A; both of whom experienced clinical and image improvement after treatment.
authors: Department of Neurology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
authors: HongMei
authors: H
authors: Zhao
authors: Department of Neurology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
authors: YaJun
authors: Y
authors: Lian
mesh_terms: D065087:Acetylcholine Release Inhibitors / Q000627:therapeutic use*; D000328:Adult; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D018810:Magnetic Resonance Angiography; D011928:Raynaud Disease / Q000000981:diagnostic imaging / Q000188:drug therapy*
chemical_list: D065087:Acetylcholine Release Inhibitors; D019274:Botulinum Toxins, Type A
keywords: Raynaud's phenomenon; botulinum toxin type A